Dilated Cardiomyopathy Risk in Patients with Coronavirus Disease 2019: How to Identify and Characterise it Early?
Multiple lines of evidence have shown that elevated blood troponin is strongly associated with poor prognosis in patients with the novel coronavirus disease 2019 (COVID-19). Possible mechanisms of myocardial injury in COVID-19 include ischaemia due to circulatory and respiratory failure, epicardial...
Main Authors: | Maki Komiyama, Koji Hasegawa, Akira Matsumori |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2020-05-01
|
Series: | European Cardiology Review |
Online Access: | https://www.ecrjournal.com/articleindex/ecr.2020.17 |
Similar Items
-
Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
by: Maki Komiyama, et al.
Published: (2021-09-01) -
Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness
by: Maki Komiyama, et al.
Published: (2020-08-01) -
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
by: Maki Komiyama, et al.
Published: (2020-04-01) -
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
by: Maki Komiyama, et al.
Published: (2020-07-01) -
Genetic risk factors for dilated cardiomyopathy
by: T. G. Vaikhanskaya, et al.
Published: (2021-11-01)